Mark Newcomer Sells 61,000 Shares of Paysign, Inc. (NASDAQ:PAYS) Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 61,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $2.89, for a total value of $176,290.00. Following the transaction, the chief executive officer now owns 9,075,886 shares of the company’s stock, valued at $26,229,310.54. This trade represents a 0.67 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Mark Newcomer also recently made the following trade(s):

• On Thursday, January 23rd, Mark Newcomer sold 12,000 shares of Paysign stock. The stock was sold at an average price of $2.85, for a total value of $34,200.00.
• On Monday, December 9th, Mark Newcomer sold 41,000 shares of Paysign stock. The shares were sold at an average price of $3.31, for a total transaction of $135,710.00.
• On Wednesday, November 20th, Mark Newcomer sold 25,000 shares of Paysign stock. The stock was sold at an average price of $3.27, for a total transaction of $81,750.00.
• On Monday, November 18th, Mark Newcomer sold 40,000 shares of Paysign stock. The shares were sold at an average price of $3.24, for a total transaction of $129,600.00.

Paysign Price Performance

Shares of PAYS stock traded up $0.04 during trading hours on Thursday, reaching $2.90. 196,394 shares of the company were exchanged, compared to its average volume of 321,771. Paysign, Inc. has a fifty-two week low of $2.70 and a fifty-two week high of $5.59. The stock’s fifty day moving average is $3.16 and its two-hundred day moving average is $3.91. The company has a market cap of $155.30 million, a price-to-earnings ratio of 19.33 and a beta of 0.95.

Paysign (NASDAQ:PAYS) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.02. The firm had revenue of $15.26 million for the quarter, compared to the consensus estimate of $14.96 million. Paysign had a return on equity of 30.64% and a net margin of 14.28%. During the same quarter in the prior year, the business earned $0.02 EPS. On average, research analysts anticipate that Paysign, Inc. will post 0.21 earnings per share for the current year.

Analyst Ratings Changes

PAYS has been the subject of several recent analyst reports. Lake Street Capital started coverage on shares of Paysign in a report on Friday, December 20th. They set a “buy” rating and a $6.00 price objective for the company. Barrington Research reiterated an “outperform” rating and issued a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th.

Hedge Funds Weigh In On Paysign

Hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC grew its stake in shares of Paysign by 25.0% during the second quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock worth $6,484,000 after purchasing an additional 301,000 shares during the period. Joule Financial LLC acquired a new position in shares of Paysign during the 3rd quarter worth about $1,478,000. Royce & Associates LP bought a new stake in shares of Paysign in the 3rd quarter valued at about $814,000. Sanctuary Advisors LLC raised its position in shares of Paysign by 4.3% in the 3rd quarter. Sanctuary Advisors LLC now owns 121,089 shares of the company’s stock valued at $419,000 after acquiring an additional 5,000 shares during the period. Finally, GSA Capital Partners LLP boosted its stake in Paysign by 31.2% during the 3rd quarter. GSA Capital Partners LLP now owns 117,028 shares of the company’s stock worth $429,000 after acquiring an additional 27,829 shares during the last quarter. Institutional investors own 25.89% of the company’s stock.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.